Shares of Sabra Health Care REIT, Inc. (NASDAQ:SBRA – Get Free Report) have been assigned an average rating of “Moderate Buy” from the seven research firms that are covering the firm, MarketBeat Ratings reports. Three analysts have rated the stock with a hold rating, three have assigned a buy rating and one has given a strong buy rating to the company. The average 1 year price target among brokerages that have covered the stock in the last year is $19.17.
A number of analysts recently issued reports on the stock. Mizuho restated a “neutral” rating and set a $20.00 target price on shares of Sabra Health Care REIT in a research report on Thursday, December 5th. Truist Financial cut Sabra Health Care REIT from a “buy” rating to a “hold” rating and decreased their price objective for the stock from $18.00 to $17.00 in a report on Friday, January 17th. JMP Securities upgraded Sabra Health Care REIT from a “market perform” rating to an “outperform” rating and set a $20.00 target price for the company in a research note on Tuesday, January 7th. Finally, Citizens Jmp raised Sabra Health Care REIT from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, January 7th.
View Our Latest Stock Report on Sabra Health Care REIT
Hedge Funds Weigh In On Sabra Health Care REIT
Sabra Health Care REIT Stock Performance
NASDAQ SBRA opened at $16.81 on Thursday. The company has a quick ratio of 4.16, a current ratio of 4.32 and a debt-to-equity ratio of 0.88. Sabra Health Care REIT has a fifty-two week low of $13.31 and a fifty-two week high of $20.03. The business has a fifty day moving average of $16.77 and a 200-day moving average of $17.63. The stock has a market cap of $4.00 billion, a price-to-earnings ratio of 31.72, a price-to-earnings-growth ratio of 1.97 and a beta of 1.25.
Sabra Health Care REIT (NASDAQ:SBRA – Get Free Report) last released its earnings results on Wednesday, February 19th. The real estate investment trust reported $0.36 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.36. Sabra Health Care REIT had a net margin of 18.02% and a return on equity of 4.60%. The company had revenue of $182.35 million for the quarter, compared to analyst estimates of $178.01 million. As a group, analysts predict that Sabra Health Care REIT will post 1.45 earnings per share for the current fiscal year.
Sabra Health Care REIT Announces Dividend
The company also recently declared a quarterly dividend, which was paid on Friday, February 28th. Shareholders of record on Friday, February 14th were paid a dividend of $0.30 per share. The ex-dividend date was Friday, February 14th. This represents a $1.20 annualized dividend and a yield of 7.14%. Sabra Health Care REIT’s dividend payout ratio is presently 226.42%.
Sabra Health Care REIT Company Profile
Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.
See Also
- Five stocks we like better than Sabra Health Care REIT
- Why Are Stock Sectors Important to Successful Investing?
- Bearish Investors Can Seek Refuge in Recession-Resistant ETFs
- What is a Special Dividend?
- 3 Oversold Magnificent Seven Stocks at Key Levels: Buy Now?
- How to Use High Beta Stocks to Maximize Your Investing Profits
- 3M to Hit $175 by Mid-Year, and Higher Highs Are Likely
Receive News & Ratings for Sabra Health Care REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Health Care REIT and related companies with MarketBeat.com's FREE daily email newsletter.